In unusual business cooperation, biotechnology modern (Nasdaq stock code: MRNA) And the king of carpooling Uber Technology (New York Stock Exchange: UBER) A project is being collaborated on to raise awareness of coronavirus vaccines.
According to a joint press release issued by the two companies, the two companies will “first cooperate to provide accessible, credible information about vaccine safety through Uber’s in-app messaging… [and] Work with public health and other organizations to find more opportunities to support ongoing efforts to expand access to the COVID-19 vaccine. “
Moderna has developed one of the only two coronavirus vaccines that have been granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) and brought it to the market.Its mRNA-1273 and Pfizer with Biological TechnologyCurrently, its BNT162b2 has been distributed and managed nationwide. Both deployments are progressing slowly. Even with trivial results, this new initiative will be welcomed.
In addition to raising awareness of coronavirus vaccines, Moderna and Uber also considered more direct ways to vaccinate Americans. These measures include embedding Uber’s cycling schedule into immunization appointments and other measures.
In the press release, Moderna CEO Stephane Bancel stated that this is only the first in a series of collaborations in this biotechnology field.
Bancel said: “As part of our commitment to address COVID-19, Moderna will work with a coalition of partners to educate, build trust and raise awareness of the importance of vaccination in communities affected by the pandemic.” Those partners are not identified.
Last month, Uber promised to provide 10 million free or discounted ride services so people can get vaccinated. The initiative aims to provide services to disadvantaged people.